CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Lees-Rolfe Garth Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +432,853 | 432,853 | ||
| 2025-01-03 | Freeman Roy Lester Director | Grant or award · Stock Option (Right to Buy) | +344,452 | 344,452 | ||
| 2025-01-03 | Freeman Roy Lester Director | Grant or award · Stock Option (Right to Buy) | +172,191 | 172,191 | ||
| 2025-01-03 | Freeman Roy Lester Director | Grant or award · Stock Option (Right to Buy) | +316,647 | 316,647 | ||
| 2025-01-03 | BERMAN DENNIS N Director | Grant or award · Stock Option (Right to Buy) | +344,452 | 344,452 | ||
| 2025-01-03 | BERMAN DENNIS N Director | Grant or award · Stock Option (Right to Buy) | +172,191 | 172,191 | ||
| 2025-01-03 | BERMAN DENNIS N Director | Grant or award · Stock Option (Right to Buy) | +316,647 | 316,647 | ||
| 2024-10-21 | Canner David Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-10-21 | Bellini Roberto Director | Purchase | +1,460,000 | $1.37 | $2.0M | 1,460,000 |
| 2024-10-21 | Bellini Roberto Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-10-21 | Kush Arvind Director | Purchase | +145,000 | $1.37 | $199K | 145,000 |
| 2024-10-21 | Kush Arvind Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-10-21 | Munshi Amit Director | Purchase | +365,000 | $1.37 | $500K | 365,000 |
| 2024-10-21 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-07-16 | GRINT PAUL C Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-07-16 | Dion Gisele Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-07-16 | BERMAN DENNIS N Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-07-16 | Freeman Roy Lester Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-04-01 | Werner Milton H. President and CEO | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2024-04-01 | Lees-Rolfe Garth Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 |
Page 6 of 9 · 163 trades